Masayuki Kyomoto Selected Research

Polyethylene (Polythene)

9/2015	Prevention of bacterial adhesion and biofilm formation on a vitamin E-blended, cross-linked polyethylene surface with a poly(2-methacryloyloxyethyl phosphorylcholine) layer.
7/2015	Influences of dehydration and rehydration on the lubrication properties of phospholipid polymer-grafted cross-linked polyethylene.
3/2014	Grafting of poly(2-methacryloyloxyethyl phosphorylcholine) on polyethylene liner in artificial hip joints reduces production of wear particles.
3/2014	Long-term hip simulator testing of the artificial hip joint bearing surface grafted with biocompatible phospholipid polymer.
6/2012	Biomimetic hydration lubrication with various polyelectrolyte layers on cross-linked polyethylene orthopedic bearing materials.
8/2011	Cartilage-mimicking, high-density brush structure improves wear resistance of crosslinked polyethylene: a pilot study.
12/2009	Superlubricious surface mimicking articular cartilage by grafting poly(2-methacryloyloxyethyl phosphorylcholine) on orthopaedic metal bearings.
11/2009	[Progress of research in osteoarthritis. Invention of longer lasting artificial joints].
9/2007	Effects of photo-induced graft polymerization of 2-methacryloyloxyethyl phosphorylcholine on physical properties of cross-linked polyethylene in artificial hip joints.
7/2007	Enhanced wear resistance of modified cross-linked polyethylene by grafting with poly(2-methacryloyloxyethyl phosphorylcholine).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Kyomoto Research Topics

Disease

9	Osteolysis 03/2014 - 07/2007
2	Fatigue 03/2015 - 10/2006
1	Knee Osteoarthritis 01/2022
1	Thromboembolism 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Infections 09/2015
1	Dehydration (Water Stress) 07/2015
1	Stress Fractures (Stress Fracture) 03/2015
1	Foreign-Body Reaction 01/2011
1	Weight Loss (Weight Reduction) 01/2007

Drug/Important Bio-Agent (IBA)

13	Polyethylene (Polythene)IBA 09/2015 - 10/2006
3	PolymersIBA 01/2022 - 07/2007
3	Phospholipids (Phosphatides)FDA LinkGeneric 07/2015 - 07/2007
1	HydrogelsIBA 01/2022
1	polyetheretherketoneIBA 01/2019
1	Vitamin K FDA Link 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Vitamin E FDA LinkGeneric 03/2015
1	2-methacryloyloxyethyl phosphorylcholineIBA 03/2014
1	CytokinesIBA 01/2011
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011

Therapy/Procedure

2	Hip Replacement Arthroplasty (Total Hip Replacement) 09/2015 - 03/2014
1	Injections 01/2022
1	Fluid Therapy (Oral Rehydration Therapy) 07/2015
1	Reoperation 11/2009